
TY  - JOUR
TI  - Posters
JO  - Journal of Gastroenterology and Hepatology
VL  - 19
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2004.03623.x
DO  - doi:10.1111/j.1440-1746.2004.03623.x
SP  - A324
EP  - A500
PY  - 2004
ER  - 

AU  - Kean, Walter F.
AU  - Rainsford, K.D.
AU  - Buchanan, W. Watson
C7  - pp. 237-312
TI  - Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases
SN  - 9781118743386
UR  - https://doi.org/10.1002/9781118743614.ch6
DO  - doi:10.1002/9781118743614.ch6
SP  - 237-312
KW  - chronic diseases
KW  - Ibuprofen
KW  - juvenile idiopathic arthritis
KW  - NSAIDs
KW  - osteoarthritis
KW  - painful diseases
KW  - rheumatic diseases
KW  - rheumatoid arthritis
PY  - 2004
AB  - Summary In many of the phase III and IV trials featuring the newer NSAIDs and the coxibs, ibuprofen was used as a comparison for the establishment of efficacy as well as safety. As a result a large amount of data has been accumulated on the clinical effects of these drugs in comparison with ibuprofen, some of which is reviewed in this chapter. There is evidence to show that ibuprofen is a safe and effective ?first-line? NSAID for many rheumatic patients. The evidence shows that mostly it is preferable to paracetamol in osteoarthritis. Aspects of the clinical pharmacology and toxicology of ibuprofen relevant to its use in rheumatic diseases and various pain states are briefly reviewed. Ibuprofen has a general profile of adverse drug reactions (ADRs) and toxicity that is similar to that of other NSAIDs in rheumatic patients. The chapter focuses on rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), and osteoarthritis.
ER  - 

TY  - JOUR
TI  - Proceedings of SCANNING 2006 April 25–27, 2006 Washington, D.C., USA
JO  - Scanning
JA  - Scanning
VL  - 28
IS  - 2
SN  - 9781118743386
UR  - https://doi.org/10.1002/sca.4950280201
DO  - doi:10.1002/sca.4950280201
SP  - 57
EP  - 131
PY  - 2006
ER  - 

TY  - JOUR
TI  - Biology of bone marrow transplantation
JO  - Journal of Supramolecular Structure
JA  - J. Supramol. Struct.
VL  - 14
IS  - S4
SN  - 9781118743386
UR  - https://doi.org/10.1002/jss.400140502
DO  - doi:10.1002/jss.400140502
SP  - 1
EP  - 43
PY  - 1980
ER  - 

TY  - JOUR
TI  - Oral and Poster Manuscripts
JO  - Influenza and Other Respiratory Viruses
VL  - 5
IS  - s1
SN  - 9781118743386
UR  - https://doi.org/10.1111/j.1750-2659.2011.00209.x
DO  - doi:10.1111/j.1750-2659.2011.00209.x
SP  - 54
EP  - 442
PY  - 2011
ER  - 

TY  - JOUR
TI  - Pathological Society of Great Britain and Ireland 155th Meeting, 8–10 July 1987 at the University of Southampton, Joint Meeting with the British Society for Neuropathology and the British Society for Mycopathology
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 152
IS  - 3
SN  - 9781118743386
UR  - https://doi.org/10.1002/path.1711520307
DO  - doi:10.1002/path.1711520307
SP  - 183A
EP  - 246A
PY  - 1987
ER  - 

TY  - JOUR
TI  - supplement
JO  - Respirology
VL  - 7
IS  - s1
SN  - 9781118743386
UR  - https://doi.org/10.1111/j.1440-1843.2004.supp_2.x
DO  - doi:10.1111/j.1440-1843.2004.supp_2.x
SP  - A15
EP  - A66
PY  - 2002
ER  - 

TY  - JOUR
TI  - Poster Presentation – Respiratory Infections (Non-Tuberculosis)
JO  - Respirology
JA  - Respirology
VL  - 19
IS  - S3
SN  - 9781118743386
UR  - https://doi.org/10.1111/resp.12417_14
DO  - doi:10.1111/resp.12417_14
SP  - 208
EP  - 227
PY  - 2014
ER  - 

TY  - JOUR
TI  - PAPERS BY AUTHOR
JO  - Annals of the New York Academy of Sciences
JA  - Annals of the New York Academy of Sciences
VL  - 634
IS  - 1
SN  - 9781118743386
UR  - https://doi.org/10.1111/j.1749-6632.1992.tb00008.x
DO  - doi:10.1111/j.1749-6632.1992.tb00008.x
SP  - 7
EP  - 179
PY  - 1992
ER  - 

C7  - pp. 1.1-1.84
TI  - Index
SN  - 9781555818807
UR  - https://doi.org/10.1128/9781555818814.index
DO  - doi:10.1128/9781555818814.index
SP  - 1.1-1.84
PY  - 1992
ER  - 

C7  - pp. 683-695
TI  - Index
SN  - 9781405157384
UR  - https://doi.org/10.1002/9781444317008.index
DO  - doi:10.1002/9781444317008.index
SP  - 683-695
PY  - 1992
ER  - 

TY  - JOUR
TI  - POSTER DISCUSSION SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 9781405157384
UR  - https://doi.org/10.1111/j.1398-9995.2008.01759.x
DO  - doi:10.1111/j.1398-9995.2008.01759.x
SP  - 78
EP  - 157
PY  - 2008
ER  - 

TY  - JOUR
TI  - 42nd Annual Meeting of the German–Speaking Mycological Society (DMykG)
JO  - Mycoses
VL  - 51
IS  - 5
SN  - 9781405157384
UR  - https://doi.org/10.1111/j.1439-0507.2007.01598.x
DO  - doi:10.1111/j.1439-0507.2007.01598.x
SP  - 365
EP  - 436
PY  - 2008
ER  - 

TY  - JOUR
TI  - Research Abstract Program of the 15th Annual ACVIM Forum
JO  - Journal of Veterinary Internal Medicine
VL  - 11
IS  - 2
SN  - 9781405157384
UR  - https://doi.org/10.1111/j.1939-1676.1997.tb00082.x
DO  - doi:10.1111/j.1939-1676.1997.tb00082.x
SP  - 97
EP  - 151
PY  - 1997
ER  - 

C7  - pp. 221-266
TI  - Hematopoietic System
SN  - 9780813817538
UR  - https://doi.org/10.1002/9780470344590.ch5
DO  - doi:10.1002/9780470344590.ch5
SP  - 221-266
KW  - hematopoietic system
KW  - metaclopramide
KW  - cyclooxygenase
KW  - erythematosus
KW  - stress test
PY  - 1997
AB  - Summary This chapter contains section titled: Hematopoiesis, Hematology, and Hemostasis Immune System Inflammation Ex Vivo Living Systems Cardiovascular: Ex Vivo Hepatic: Ex Vivo Hematopoietic: Lymphocytes (EX VIVO) Hematopoietic: Macrophages and Monocytes (EX VIVO) Hematopoietic: Neutrophils (EX VIVO) Hematopoietic: Platelets (EX VIVO) Hematopoietic: Red Blood Cells (EX VIVO) Musculoskeletal: Ex Vivo Neoplastic Disease: Ex Vivo Respiratory: Ex Vivo
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 9780813817538
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00029.x
DO  - doi:10.1111/j.1538-7836.2007.tb00029.x
SP  - P-T-401
EP  - P-T-700
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 9780813817538
UR  - https://doi.org/10.1111/all.12251
DO  - doi:10.1111/all.12251
SP  - 337
EP  - 497
PY  - 2013
ER  - 

AU  - Oleinikov, Andrew V.
AU  - Gray, Matthew D.
C7  - pp. 1-40
TI  - RNA Interference: The Next Gene-Targeted Medicine
UR  - https://doi.org/10.1002/9780470571224.pse324
DO  - doi:10.1002/9780470571224.pse324
SP  - 1-40
KW  - gene expression
KW  - RNA interference
KW  - molecular research
KW  - drug development
PY  - 2013
AB  - Abstract The newest laboratory method for modulating gene expression, RNA interference (RNAi), has gained rapid interest throughout the world of molecular research, and is being actively pursued as the next ?gene-targeted medicine.? RNAi is a process in which double-stranded RNA (dsRNA) directs the specific degradation of a corresponding target mRNA. This article describes the main ideas, approaches, and technological directions that may guide the medical researcher interested in using RNAi methodologies to identify and develop new drug candidates.
ER  - 

TY  - JOUR
TI  - Skin bioengineering methods and ICD
JO  - Experimental Dermatology
VL  - 6
IS  - 5
UR  - https://doi.org/10.1111/j.1600-0625.1997.tb00170.x
DO  - doi:10.1111/j.1600-0625.1997.tb00170.x
SP  - 249
EP  - 270
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** Eighty-eighth Annual Meeting, March 25–28, 1987 Marriott's Orlando World Center, Orlando, Florida
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 41
IS  - 2
UR  - https://doi.org/10.1038/clpt.1987.24
DO  - doi:10.1038/clpt.1987.24
SP  - 155
EP  - 248
PY  - 1987
AB  - Clinical Pharmacology and Therapeutics (1987) 41, 155?248; doi:10.1038/clpt.1987.24
ER  - 
